Effective 7/28/2025: Texas Medicaid Preferred Drug List Updates
Date: 07/15/25
The Texas Health and Human Services Commission (HHSC) will publish the semi-annual update of the Preferred Drug List (PDL) on Monday, July 28, 2025. The update will be based on changes presented at the Vendor Drug Program (VDP) Drug Utilization Review (DUR) Board meetings in January 2025 and April 2025. Superior HealthPlan follows the Texas Medicaid Vendor Drug Formulary and the PDL.
The tables below summarize some of the anticipated noteworthy changes from the January 2025 and April 2025 DUR meetings.
DRUG CLASS | DRUG NAME | CURRENT | STATUS CHANGE ON 7/28/2025 |
Acne Agents, topical | Epiduo forte gel w/pump | Preferred | Non-Preferred |
Acanya gel w/pump | Non-Preferred | Preferred | |
Atralin (topical) gel | Non-Preferred | Preferred | |
Cleocin T (topical) lotion | Non-Preferred | Preferred | |
Clindagel (topical) gel daily | Non-Preferred | Preferred | |
Clindamycin (topical) (AG) gel | Non-Preferred | Preferred | |
Analgesics, narcotics long (Oral)
| Oxycontin Tab ER 12H | Non-Preferred | Preferred |
Analgesics, narcotics short (Oral)
| Tramadol 25mg (oral) tablet | Not Rated | Non-Preferred |
Tramadol 75mg (oral) tablet | Not Rated | Non-Preferred | |
Antidepressants, Other (Oral) | Effexor XR Cap ER 24H | Non-Preferred | Preferred |
Zurzuvae (oral) cap | Non-Preferred | Preferred | |
Antimigraine Agents, other (Oral) | Qulipta tablet | Non-Preferred | Preferred |
Cytokine and CAM Antagonists (subcutaneous) | Cimzia 200mg/ml syr kit (SQ) | Not Rated | Non-Preferred |
Tremfya 200mg/2ml pen (SQ) | Not Rated | Non-Preferred | |
Skyrizi syr/pen injctr (SQ) | Non-Preferred | Preferred | |
Immunomodulators, Atopic Dermatitis (Topical) | Vtama (topical) cream | Not Rated | Non-Preferred |
Zoryve (topical) cream and foam | Non-Preferred | Preferred | |
Intranasal Rhinitis Agents (Nasal) | Dymista (Nasal) spray/pump | Non-Preferred | Preferred |
Omnaris (nasal) spray/pump | Non-Preferred | Preferred | |
Qnasal (nasal) HFA AER | Non-Preferred | Preferred | |
Neuropathic Pain (Oral) | Lyrica solution | Non-Preferred | Preferred |
Lyrica CR tablet ER | Non-Preferred | Preferred | |
Neurontin capsule/tablet | Non-Preferred | Preferred | |
Neurontin solution | Non-Preferred | Preferred | |
PAH Agents (Oral) | Sildenafil citrate susp recon | Non-Preferred | Preferred |
Proton Pump Inhibitors (Oral) | Dexilant capsule DR | Preferred | Non-Preferred |
Stimulants and Related Agents (Oral) | Dexedrine ER capsule | Non-Preferred | Preferred |
Ritalin LA (oral) CPBP | Non-Preferred | Preferred | |
Provigil tablet | Non-Preferred | Preferred | |
Oncology, (Oral) | Itovebi tablet | Not Rated | Preferred |
Voranigo tablet | Not Rated | Preferred |
Please note: The tables are not the complete list of changes. Please reference the Texas Medicaid PDL for a complete list of recommended medications or visit DUR Board webpage on the Texas Vendor Drug website for all decisions.